India · Delayed Price · Currency is INR Kimia Biosciences Company Description
Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India.
The company offers and develops APIs in the categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, lipid lowering agents, vitamin, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals.
It exports its products. Kimia Biosciences Limited was formerly known as Laurel Organics Ltd and changed its name to Kimia Biosciences Limited January 2019.
The company was incorporated in 1993 and is based in New Delhi, India.
| Country | India |
| Founded | 1993 |
| Industry | Medicinal Chemicals and Botanical Products |
| Employees | 250 |
| CEO | Sameer Goel |
Contact Details
Address: 974, Aggarwal Millennium Tower II New Delhi, Haryana 110034 India | |
| Phone | 91 11 4706 3600 |
| Website | kimiabiosciences.com |
Stock Details
| Ticker Symbol | 530313 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Sameer Goel | Chief Executive Officer |
| Naveen Sharma | Chief Financial Officer |
| Vijayasekhar Kaku | Chief Operating Officer |